Bio News
Eli Lilly’s Mounjaro generated 13.5 billion Brazilian reais in sales and reached 3 million patients within one year of its launch in Brazil. As a result, Lilly’s Brazilian subsidiary entered the company’s top 10 markets by revenue, and sales in 2026 are expected to more than double. As competition intensifies, Lilly plans to maintain its market position through the GIP/GLP-1 dual-agonist mechanism and follow-on oral drugs.
Biobook Team
biobookmedia@biobook.co.krRural Development Administration Develops Two Molecular Markers to Identify Leaf Splitting in Squash
MFDS Begins Distribution of Internationally Certified Reference Materials, Including 24 New Items, for a Total of 882
Ministry of Trade, Industry and Energy signs agreement to promote biotech and medical devices in Gangwon; site visit set for the 14th
RDA develops technology to produce anti-inflammatory exosomes for pets and files patent application
HLB Submits FDA Resubmission for First-Line Liver Cancer Treatment
Celltrion Reports Third-Quarter Revenue of 1.5 Trillion Won and Operating Profit of 510 Billion Won, Up 69% Year Over Year
Rural Development Administration Develops Two Molecular Markers to Identify Leaf Splitting in Squash
MFDS Begins Distribution of Internationally Certified Reference Materials, Including 24 New Items, for a Total of 882
Ministry of Trade, Industry and Energy signs agreement to promote biotech and medical devices in Gangwon; site visit set for the 14th
